PDL BioPharma
PDL BioPharma engages in intellectual property asset management and patent portfolio and related assets investment activities.
Business Model:
Revenue: $27.8M
Employees: 201-500
Rankings
Industries / Tags:
Detailed PDL BioPharma Information
Geographic Data
Address: 932 Southwood Blvd
City: Incline Village
State: NV
Zip: 89451
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$150M
Social
Metrics
5,156,755Website Global Rank
1,902Website Monthly Traffic
Twitter Followers
Description
PDL BioPharma engages in intellectual property asset management and patent portfolio and related assets investment activities.
Contact Phone:
+17758328500
Contact Email:
PDL BioPharma went public on 1/29/1992 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/29/1992
Ticker Symbol:
PDLI
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2014 | kaleo | Debt | 150M |
| 11/2013 | Durata Therapeutics | Post-IPO Equity | 0 |
| 4/2019 | Evofem Biosciences | Post-IPO Equity | 0 |
| 2/2014 | Direct Flow Medical | Debt Financing | 0 |
| 2/2014 | Paradigm Spine | Debt Financing | 0 |
| 5/2016 | Noden Pharma | Corporate Round | 0 |
| 6/2019 | Evofem Biosciences | Post-IPO Equity | 0 |
| 10/2013 | LENSAR, Inc. | Debt | 60M |
| 10/2013 | LENSAR, Inc. | Equity | 27M |
| 6/2019 | Evofem Biosciences | Post-IPO Equity | 0 |
| 4/2019 | Evofem Biosciences | Post-IPO Equity | 0 |
| 5/2016 | Noden Pharma | Corporate Round | 0 |
| 4/2014 | kaleo | Debt Financing | 0 |
| 2/2014 | Paradigm Spine | Debt Financing | 0 |
| 2/2014 | Direct Flow Medical | Debt Financing | 0 |
| 11/2013 | Durata Therapeutics | Post-IPO Equity | 0 |
| 10/2013 | LENSAR, Inc. | Venture Round | 0 |
| 10/2013 | LENSAR, Inc. | Debt Financing | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Debt | $150M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2005 | ESP Pharma |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
